Preveceutical Med Inc New (OP:PRVCF)

0.0169 +0.0022 (+14.97%)

Streaming Delayed Price Updated: 9:30 AM EST, Mar 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Preveceutical Med Inc New

PreveCeutical Announces Filing of Patent for Delivery of CNS-Active Agents

February 09, 2026

Vancouver, British Columbia--(Newsfile Corp. - February 9, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") is...

Via Newsfile

Topics Intellectual Property

BioGene Therapeutics Inc. Appoints Dr. Francis Tavares, PhD., as Chief Technology Officer

August 20, 2025

Vancouver, British Columbia--(Newsfile Corp. - August 20, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the...

Via Newsfile

BioGene Therapeutics Inc. Appoints Dr. Kamal Albarazanji as Senior Director of Metabolic Research

August 19, 2025

Vancouver, British Columbia--(Newsfile Corp. - August 19, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the...

Via Newsfile

Topics Intellectual Property

PreveCeutical Announces Rescheduled Date for Annual General and Special Meeting

July 09, 2025

Vancouver, British Columbia--(Newsfile Corp. - July 9, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"),...

Via Newsfile

PreveCeutical Welcomes Dr. Francis Tavares, PhD. As Chief Technology Officer

June 30, 2025

Vancouver, British Columbia--(Newsfile Corp. - June 30, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"),...

Via Newsfile

PreveCeutical Welcomes Dr. Deepak Sampath, PhD. as Corporate Advisor

June 02, 2025

Vancouver, British Columbia--(Newsfile Corp. - June 2, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"),...

Via Newsfile

Topics Intellectual Property

PreveCeutical Welcomes Stephen Glover as Corporate Advisor

May 26, 2025

Vancouver, British Columbia--(Newsfile Corp. - May 26, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the...

Via Newsfile

PreveCeutical Medical Inc. Announces Launch of New Website for BioGene Therapeutics Inc., Expanding Its Digital Presence to Enhance Accessibility and Awareness of Innovative Therapies

May 14, 2025

Vancouver, British Columbia--(Newsfile Corp. - May 14, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical"), a...

Via Newsfile

PreveCeutical Files Two Family Patents of Sol-Gel Cannabinoid Formulation and Antiviral Use & Cyclic Peptides and Uses Thereof

June 28, 2023

Vancouver, British Columbia--(Newsfile Corp. - June 28, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"),...

Via Newsfile

Topics Intellectual Property

PreveCeutical Medical - Sol-Gel and Uses thereof Patent Update

May 30, 2023

Vancouver, British Columbia--(Newsfile Corp. - May 30, 2023) - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF)...

Via Newsfile

Topics Intellectual Property

PreveCeutical Medical Launches Clinical Artificial Intelligence Division

April 24, 2023

Vancouver, British Columbia--(Newsfile Corp. - April 24, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company"...

Via Newsfile

Topics Artificial Intelligence

PreveCeutical Medical Announces Frontiers Media SA Publication Featuring Data from its Analgesic Program for the Treatment of Peptide-based Therapeutics for Moderate to Severe Pain

April 04, 2023

Synthesized Kappa Opioid Receptors (KOP) Appear to be Devoid of Many Problematic Mu Receptor Side-effects Such as Tolerance, Addiction, Sedation,...

Via Newsfile

PreveCeutical Initiates Non-Analgesic (Painkiller) Program, Clinical Development Program & Disclosure Committee

March 20, 2023

Vancouver, British Columbia--(Newsfile Corp. - March 20, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"),...

Via Newsfile

PreveCeutical - International Filing of Thermoresponsive Sol-Gels Containing Cannabinoids & Uses Thereof

March 06, 2023

Vancouver, British Columbia--(Newsfile Corp. - March 6, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"),...

Via Newsfile

Topics Intellectual Property

Appointment of C. Evan Ballantyne to PreveCeutical's Board of Directors

February 21, 2023

Vancouver, British Columbia--(Newsfile Corp. - February 21, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces...

Via Newsfile

PreveCeutical Awards ICON Analgesic Program (Painkiller) Clinical Development

February 07, 2023

Vancouver, British Columbia--(Newsfile Corp. - February 7, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"),...

Via Newsfile

PreveCeutical - Australian Patent Granted for Disulfide Bond Containing Compounds

January 25, 2023

Vancouver, British Columbia--(Newsfile Corp. - January 25, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"),...

Via Newsfile

Topics Bonds Intellectual Property

PreveCeutical - Background IP, US Patent Granted Disulfide Bond Containing Compounds

January 23, 2023

Vancouver, British Columbia--(Newsfile Corp. - January 23, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company"...

Via Newsfile

Topics Bonds Intellectual Property

PreveCeutical - Dynorphin Peptides (Painkiller) and Uses Thereof Patent Update and Officer Update

January 17, 2023

Vancouver, British Columbia--(Newsfile Corp. - January 17, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"),...

Via Newsfile

Topics Intellectual Property

PreveCeutical Enters into License Option Agreement with Endosane Pharmaceuticals

January 12, 2023

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"),...

Via Newsfile

PreveCeutical Signs Intercompany Sol-Gel License Agreement

January 09, 2023

Vancouver, British Columbia--(Newsfile Corp. - January 9, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"),...

Via Newsfile

Topics Intellectual Property

Appointment of Sachin Nanavati to PreveCeutical's Board of Directors

September 06, 2022

Vancouver, British Columbia--(Newsfile Corp. - September 6, 2022) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company"...

Via Newsfile

PreveCeutical Files International Patent Application for Sol-Gel Cannabinoid Formulation for Antiviral Use

November 29, 2021

Vancouver, British Columbia--(Newsfile Corp. - November 29, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or...

Via Newsfile

Topics Cannabis Death Intellectual Property

PreveCeutical Signs License Agreement for Exclusive Rights to Use UniQuest's Sol-Gel Technology for Delivery of Cannabinoids

November 18, 2021

Vancouver, British Columbia--(Newsfile Corp. - November 18, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"),...

Via Newsfile

Topics Intellectual Property

PreveCeutical Files International Patent Application for its Dynorphin Peptides

July 07, 2021

Vancouver, British Columbia--(Newsfile Corp. - July 7, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company"...

Via Newsfile

Topics Cannabis Intellectual Property

PreveCeutical Provides Corporate Update

May 31, 2021

Vancouver, British Columbia--(Newsfile Corp. - May 31, 2021) - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF)...

Via Newsfile

Topics Intellectual Property

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.